Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer
Condition:   Non Small Cell Lung Cancer Intervention:   Sponsor:   Hellenic Cooperative Oncology Group Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2020 Category: Research Source Type: clinical trials

Erlotinib for Hepatocellular Carcinoma Chemoprevention
Condition:   Cirrhosis, Liver Intervention:   Drug: Erlotinib Hydrochloride Sponsor:   University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2019 Category: Research Source Type: clinical trials